Biochemical relapse-free survival after high dose external radiotherapy (≥78Gy) and 6 months of androgen deprivation in high-risk localized prostate cancer patients

被引:0
|
作者
Reuther, A
Reddy, C
Mahadevan, A
Kupelian, P
机构
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] MD Anderson Orlando, Orlando, FL USA
关键词
D O I
10.1016/j.ijrobp.2005.07.494
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2100
引用
收藏
页码:S289 / S290
页数:2
相关论文
共 50 条
  • [31] Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients With Localized, High-Risk Prostate Cancer
    McCall, Neal S.
    Liu, Yuan
    Patel, Sagar A.
    Hershatter, Bruce
    Moghanaki, Drew
    Godette, Karen D.
    Hanasoge, Sheela
    Patel, Pretesh
    Fischer-Valuck, Benjamin W.
    Shelton, Joseph W.
    Jani, Ashesh B.
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (06)
  • [32] Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients with Localized, High-Risk Prostate Cancer
    McCall, N. S.
    Liu, Y.
    Patel, S. A.
    Hershatter, B.
    Moghanaki, D.
    Godette, K. D.
    Hanasoge, S.
    Patel, P. R.
    Fischer-Valuck, B. W.
    Shelton, J. W.
    Jani, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E877 - E877
  • [33] Determinants of biochemical failure and distant metastases-free survival in high-risk prostate cancer patients treated with external beam radiotherapy
    Pilar, Avinash
    Bayley, Andrew
    Shehata, Danny
    Liu, Zhihui
    Berlin, Alejandro
    Catton, Charles N.
    Kong, Vickie
    Rosewall, Tara
    Gospodarowicz, Mary K.
    Craig, Tim
    Helou, Joelle
    Warde, Padraig Richard
    Chung, Peter W. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [34] Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
    Ohashi, Toshio
    Yorozu, Atsunori
    Saito, Shiro
    Momma, Tetsuo
    Nishiyama, Toru
    Yamashita, Shoji
    Shiraishi, Yutaka
    Shigematsu, Naoyuki
    RADIATION ONCOLOGY, 2014, 9
  • [35] Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
    Toshio Ohashi
    Atsunori Yorozu
    Shiro Saito
    Tetsuo Momma
    Toru Nishiyama
    Shoji Yamashita
    Yutaka Shiraishi
    Naoyuki Shigematsu
    Radiation Oncology, 9
  • [36] Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy
    Yamamoto, Yutaka
    Kiba, Keisuke
    Yoshikawa, Motokiyo
    Hirayama, Akihide
    Kunikata, Seiji
    Uemura, Hirotsugu
    RESEARCH AND REPORTS IN UROLOGY, 2016, 8 : 225 - 231
  • [37] Eighteen Months of Androgen Deprivation Therapy in Men with High-risk Prostate Cancer and the Risk of Death
    Xie, Wanling
    D'Amico, Anthony V.
    EUROPEAN UROLOGY, 2018, 74 (04) : 442 - 443
  • [38] Prognostic indicators of relapse-free and overall survival in patients with high-risk primary breast cancer following high-dose chemotherapy.
    Somlo, G
    Chu, P
    Frankel, P
    Chow, W
    Forman, S
    Leong, L
    Margolin, K
    Morgan, R
    Shibata, S
    Yen, Y
    Doroshow, J
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 243 - 243
  • [39] Androgen Deprivation Therapy and Dose-Escalated Radiotherapy for Intermediate-and High-Risk Prostate Cancer Reply
    Falchook, Aaron D.
    Basak, Ramsankar
    Chen, Ronald C.
    JAMA ONCOLOGY, 2017, 3 (02) : 281 - 281
  • [40] High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features
    C Vargas
    A Martínez
    R Galalae
    J Demanes
    A Harsolia
    L Schour
    N Nuernberg
    J Gonzalez
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 245 - 253